← Back to all bills

Controlled Substances Act - Updates

EngrossedReece Pyrtle (R)House2025–2026 Session
AI Generated

This bill updates North Carolina's Controlled Substances Act by adding dozens of newly synthesized drugs to the state's Schedule I and Schedule II controlled substance lists. These additions include synthetic opioids (such as U-47700 variants and nitazene derivatives), fentanyl derivatives, synthetic cannabinoids, and other designer drugs, while also making minor corrections to existing drug names in the statute.

Arguments in Favor

Supporters argue this bill helps law enforcement combat the emergence of dangerous designer drugs that are chemically modified to evade existing drug laws. By listing these new synthetic substances—particularly dangerous opioids and fentanyl analogs linked to overdose deaths—the state can prosecute their manufacture and distribution. Proponents contend the bill closes legal loopholes that allow drug manufacturers to create slightly altered versions of banned substances and sell them while remaining technically legal.

Arguments Against

Opponents may question whether listing individual drug variants is the most effective approach, since chemists can continually create new modifications faster than legislatures can ban them. Some argue the bill's broad language defining structural classes of drugs could inadvertently affect legitimate research, pharmaceutical manufacturing, or industrial uses unless exemptions are carefully applied. Critics might also contend that aggressive scheduling alone doesn't address underlying addiction and overdose issues without accompanying treatment and prevention resources.

AI-generated analysis based on bill text. Always verify with official sources at ncleg.gov. This is not legal or political advice.

Sponsors

Cosponsors (9)

Vote Breakdown (1 roll call)

Final Vote

House Initial PassageMar 25, 2025

On: Second Reading

Passed
117
Yea
0
Nay
0
Not Voting
3
Absent
117 Yea0 Nay
Republican70 Yea·0 Nay
Democrat47 Yea·0 Nay